MEDTECH
Fibronostics, a global leader in non-invasive, AI-driven diagnostic testing for *MAFLD/MASH patients, announced today a strategic...
Genesis is a market leader in tech-enabled RWE and HEOR Management to pursue global expansion,...
NEW YORK & SINGAPORE – August 24, 2020 – Fibronostics, a global company providing non-invasive, algorithmic...
NEW YORK, August 3, 2020 – Fibronostics, a global diagnostics company, providing non-invasive, algorithmic diagnostics to...
Ayala Healthcare Holdings, through its technology arm, Vigos, expanded its digital portfolio with a recent...